Jusko awarded 2017 William B. Abrams Lecture

Jusko is internationally known for his research in pharmacokinetics/pharmacodynamics and pharmacogenomics. He has developed mechanism-based pharmacokinetic, pharmacodynamic and disease progression models, and computational methods describing the action of various drugs and utilizes mathematical models of drug action to determine optimal dosage regimens. His research has contributed significantly to the understanding of the theoretical, basic and clinical aspects of the pharmacokinetics and pharmacodynamics of immunosuppressive agents including corticosteroids, as well as drugs used to treat diabetes, inflammation, and cancer. 

Jusko will present his lecture, titled Equations of Life and Success: How Basic Modeling Principles Govern Diverse Aspects of Pharmacology, Pharmacodynamics, and Systems Pharmacology, at the FDA’s White Oak Campus in Silver Spring, MD, on May 3.

For more than ten years, ASCPT and the FDA have invited experts from academia, industry and government to discuss advances in clinical pharmacology and drug development. These scientists have excelled in their specialty areas and are some of the most highly esteemed clinical pharmacologists in the field. Their presentations convey novel information and perspectives on fundamental aspects of clinical pharmacology. Previous lectures have included speakers from the Mayo Clinic, University of California, Children's Mercy Hospitals and Clinics and the National Institutes of Health.

The William B. Abrams Lecture is a joint educational initiative of ASCPT and the FDA. The lecture series, supported in part by The Merck Company Foundation, was established in 1999 to honor William B. Abrams, MD, an ASCPT president from 1975 to 1976.